BPC-157 — Body Protection Compound-157 — is a synthetic peptide made up of 15 amino acids. It’s derived from a naturally occurring protein found in human gastric juice, which is part of the reason researchers first became interested in it — the body already produces a version of this compound as part of its natural protective processes.

Over the past two decades, BPC-157 has become one of the most studied peptides in the repair and recovery research space, with over 100 published studies exploring its effects across a wide range of tissue types.

What Researchers Are Exploring

Gut Health & Digestive Repair

Because BPC-157 originates from a gastric protein, some of its most impressive research has focused on the gut. Studies in animal models have shown it may help protect and repair the lining of the stomach and intestines, with research exploring its effects on gastric ulcers, inflammatory bowel conditions, and intestinal tissue damage.

Tendon, Ligament & Muscle Repair

BPC-157 has attracted significant attention in musculoskeletal research. Studies have reported it may speed up the healing of tendons, ligaments, and muscles in research models — linked to its ability to increase growth factors involved in connective tissue repair.

Inflammation

Research has consistently pointed to BPC-157’s ability to reduce inflammation at injury sites in a targeted way — supporting the body’s natural healing processes rather than simply suppressing the immune response.

Blood Vessel Growth (Angiogenesis)

One of the mechanisms behind BPC-157’s healing effects is its ability to promote new blood vessel formation. By improving blood supply to damaged areas, it helps deliver the nutrients and oxygen needed for repair.

Brain & Nerve Research

An emerging area of research involves the nervous system. Studies have explored its potential to support nerve repair and protect brain cells, with research examining its effects on the dopamine and serotonin systems.

Worth Noting

BPC-157 has one of the broadest research profiles of any peptide available. Positive findings have been reported across gut, muscle, tendon, ligament, nerve, and brain tissue — which is unusual for a single compound.

For research use only. Not intended for human consumption. Not approved by the FDA or TGA.

CJC-1295 — also known as Modified GRF 1-29 — is a synthetic peptide that mimics the body’s natural Growth Hormone Releasing Hormone (GHRH). It sends a signal to the pituitary gland to release growth hormone, much like the body does naturally — but in a more controlled and consistent way.

Growth hormone plays a central role in muscle growth, fat metabolism, recovery, and overall body composition. As natural GH levels decline with age, research into peptides that can stimulate its release has become one of the most active areas in performance and longevity science.

What Researchers Are Exploring

Growth Hormone Stimulation

CJC-1295 triggers GH release in a pulsatile pattern — mimicking the body’s natural rhythm rather than flooding the system with constant levels. Studies have shown significant GH increases, making it a preferred tool for researchers studying growth hormone’s effects on the body.

Muscle Growth & Body Composition

Research has explored its downstream effects on body composition, with studies suggesting the GH elevation may support lean muscle development and improved fat metabolism.

Recovery & Repair

GH plays a well-documented role in tissue repair. Research has explored how elevated GH from CJC-1295 may support faster recovery from exercise and injury through the GH/IGF-1 pathway.

Sleep & Overnight Recovery

GH is naturally released in its largest pulses during deep sleep. Research has explored how CJC- 1295 may enhance this overnight GH release, supporting recovery processes during sleep.

Worth Noting

CJC-1295 is most frequently studied in combination with Ipamorelin — the two work through complementary pathways for synergistic GH release. We offer both individually, as a combo pack, and as a pre-blended vial.

For research use only. Not intended for human consumption. Not approved by the FDA or TGA.

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring peptide made up of nine amino acids. First isolated from cerebral venous blood in 1977, it gets its name from early research showing it could promote delta-wave sleep — the deepest, most restorative stage of sleep associated with physical recovery and growth hormone release.

Since its discovery, DSIP has attracted research interest well beyond sleep, with studies exploring its effects on stress, pain, hormonal regulation, and withdrawal symptoms.

What Researchers Are Exploring

Sleep Quality & Delta-Wave Sleep DSIP’s primary research area is its ability to promote deeper, more restorative sleep — specifically delta-wave (slow-wave) sleep. This is the sleep stage most associated with physical recovery, immune function, and natural growth hormone release. Research suggests it improves sleep quality without the sedation, dependency, or hangover effects of traditional sleep aids.

Stress & Cortisol Regulation Studies have examined DSIP’s ability to modulate the stress response, with research suggesting it may normalise cortisol levels — relevant to chronic stress and HPA axis research.

Pain Modulation Research has explored DSIP’s potential pain-reducing properties, with studies suggesting it may influence endorphin pathways and pain perception.

Hormonal Balance DSIP has been studied for its effects on growth hormone release, cortisol regulation, and LH signalling — making it of interest to researchers studying broader hormonal balance.

Worth Noting DSIP’s ability to promote deep sleep naturally — without sedation or dependency — makes it uniquely positioned. Given that deep sleep is when the body does most of its repair and growth hormone secretion, DSIP has relevance extending well beyond sleep research.

For research use only. Not intended for human consumption. Not approved by the FDA or TGA.

Epithalon (also spelled Epitalon) is a synthetic tetrapeptide — just four amino acids long — developed by Russian gerontologist Professor Vladimir Khavinson. It is based on a naturally occurring compound called Epithalamin, which is produced by the pineal gland.

Epitalon has attracted significant attention in longevity research because of one specific ability: it has been shown to activate telomerase — the enzyme that maintains and extends telomeres. Telomeres are the protective caps on the ends of chromosomes that shorten every time a cell divides. When telomeres become too short, the cell can no longer divide and either becomes dysfunctional or dies. This process is considered one of the primary mechanisms of aging.

What Researchers Are Exploring

Telomerase Activation & Telomere Length Epitalon’s defining research area is its ability to reactivate telomerase in somatic (body) cells. Studies have shown it can lengthen telomeres — essentially resetting a key part of the cellular aging clock. This has made it one of the most directly relevant compounds in aging research.

Anti-Aging & Lifespan Research Animal studies have demonstrated extended lifespan in subjects treated with Epitalon — findings attributed to its effects on telomere maintenance and cellular health. These studies have generated significant interest in human longevity research.

Pineal Gland & Melatonin As a peptide based on a pineal gland compound, Epithalon has been studied for its effects on melatonin production and circadian rhythm regulation — with some research suggesting it may restore more youthful patterns of melatonin secretion.

Antioxidant & Cellular Protection Research has explored Epithalon’s ability to reduce oxidative stress and protect cells from age- related damage — mechanisms that complement its telomere-related effects.

Worth Noting Epithalon is one of the few compounds that directly targets telomere length — a hallmark of aging at the most fundamental cellular level. Professor Khavinson’s extensive body of published research on this peptide spans decades and has made Epithalon a staple in the longevity research community.

For research use only. Not intended for human consumption. Not approved by the FDA or TGA.

GHK-Cu (Glycyl-L-Histidyl-L-Lysine:Copper) is a naturally occurring tripeptide that binds to copper. It was first identified in human plasma in 1973 by Dr. Loren Pickart, who noticed that older blood lost its ability to stimulate tissue repair compared to younger blood — and traced the difference back to this small peptide-copper complex.

Since then, GHK-Cu has become one of the most extensively studied peptides in skin science, wound healing, and anti-aging research. Its ability to influence the expression of over 4,000 genes — many involved in tissue repair and regeneration — has made it a uniquely interesting compound.

What Researchers Are Exploring

Skin Regeneration & Anti-Aging GHK-Cu is best known for its role in skin research. Studies have shown it stimulates collagen and elastin production, tightens skin, improves skin firmness, and reduces fine lines and wrinkles in research models. It’s also been shown to increase skin thickness and improve overall skin quality — making it one of the most studied anti-aging peptides.

Wound Healing Research has consistently demonstrated GHK-Cu’s ability to accelerate wound healing. It promotes the formation of new blood vessels (angiogenesis), attracts immune cells to wound sites, and stimulates the production of structural proteins needed for tissue repair.

Hair Growth Research Studies have explored GHK-Cu’s potential to stimulate hair growth by increasing follicle size and activity. Research suggests it may influence hair follicle cells in ways that promote thicker, healthier hair growth — an area that has drawn significant interest.

Antioxidant & Anti-Inflammatory Research GHK-Cu has demonstrated strong antioxidant properties in research, and studies have explored its ability to reduce inflammation and protect cells from oxidative damage — mechanisms relevant to aging, tissue degeneration, and recovery research.

Worth Noting GHK-Cu’s natural presence in the human body — combined with its remarkable ability to influence thousands of genes involved in repair and regeneration — makes it a uniquely well-supported research compound. Levels naturally decline with age, which has fuelled interest in whether supplementation can reverse age-related tissue changes.

For research use only. Not intended for human consumption. Not approved by the FDA or TGA.

Human Growth Hormone (HGH) is a naturally produced hormone that plays a key role in growth, metabolism, muscle development, and tissue repair. Medical HGH is prescribed for specific hormone deficiencies and certain medical conditions.

It has been studied for its ability to improve body composition, recovery, and bone health, but misuse carries significant health risks. HGH should only be used under appropriate medical supervision.

Kisspeptin is a family of naturally occurring peptides produced primarily in the hypothalamus. They act as the “trigger” for the reproductive hormone axis — binding to the GnRH receptor and setting off a hormonal cascade that leads to the release of LH (luteinising hormone), FSH (follicle-stimulating hormone), and ultimately sex hormones including testosterone and oestrogen.

Kisspeptin-10 is the shortest and most studied fragment of this peptide family. It retains the full biological activity of longer kisspeptin forms and has been the focus of a growing body of clinical and preclinical research due to its role as a master regulator of the reproductive system.

What Researchers Are Exploring

Reproductive Hormone Axis The most well-established area of kisspeptin research is its ability to stimulate LH release. Studies have shown that kisspeptin-10 can produce a significant, rapid increase in LH levels — with effects measurable within 30 to 45 minutes of administration. This has made it a key focus in research on hormonal stimulation and reproductive endocrinology.

Fertility Research Kisspeptin’s role in triggering the LH surge needed for ovulation has attracted significant interest in fertility research. Clinical studies have explored kisspeptin as a potential trigger agent for ovulation induction, with research suggesting it may produce an LH response that more closely mirrors the natural mid-cycle surge than existing methods.

Testosterone & Male Hormone Research In males, the LH stimulation triggered by kisspeptin directly influences testosterone production in the testes. Research has explored kisspeptin’s potential relevance to studies on testosterone levels, HPG axis function, and male reproductive health.

Sexual Function Research Beyond hormone stimulation, research has examined kisspeptin’s broader influence on sexual behaviour and function. Studies have looked at its effects on sexual brain processing and arousal, with some research suggesting it may influence aspects of libido and sexual motivation at a neurological level.

Metabolic Research More recent research has explored kisspeptin’s potential involvement in metabolic regulation. Studies in animal models have shown kisspeptin-10 reduced body weight and blood glucose levels, raising questions about its relevance to metabolic health research alongside its reproductive focus.

Worth Noting

Kisspeptin operates high up in the hormonal chain of command — it doesn’t directly stimulate testosterone or oestrogen, but rather triggers the upstream signalling that leads to their release. This mechanism-based approach to studying the reproductive axis is what makes kisspeptin research particularly relevant to researchers interested in hormonal regulation from a systems perspective.

For research use only. Not intended for human consumption. Not approved by the FDA or TGA.

Melanotan II (MT-II) is a synthetic cyclic peptide designed to mimic alpha-melanocyte stimulating hormone (α-MSH) — a natural hormone that controls skin pigmentation. Originally developed at the University of Arizona in the 1990s, it has become one of the most studied melanocortin peptides in the world.

MT-II activates multiple melanocortin receptor subtypes — particularly MC1R, MC3R, MC4R, and MC5R — which gives it a research profile that extends well beyond just tanning.

What Researchers Are Exploring

Skin Pigmentation & Tanning MT-II’s most studied area is melanogenesis — the process by which the skin produces melanin pigment. Research has shown it activates MC1R signalling in melanocytes, promoting melanin production and increased skin pigmentation without UV exposure. This has attracted significant interest in dermatology and photoprotection research.

Sexual Function Research During early tanning research, scientists discovered MT-II had notable effects on sexual arousal and function — a finding that led directly to the development of PT-141 (Bremelanotide), which went on to achieve FDA approval. MT-II’s activation of MC3R and MC4R receptors in the brain has been explored for effects on sexual desire through central nervous system pathways.

Appetite & Energy Research MT-II’s activation of MC4R has drawn interest in appetite regulation research. The melanocortin system plays a well-documented role in hunger signalling, and studies have examined MT-II’s effects on food intake and energy expenditure.

Worth Noting Melanotan II has one of the longest research histories of any synthetic melanocortin peptide. It’s the parent compound from which PT-141 (Bremelanotide) was derived — a peptide that achieved full FDA approval. Its multi-receptor activity gives it a broader research profile than more selective melanocortin agonists.

For research use only. Not intended for human consumption. Not approved by the FDA or TGA.

NAD+ (Nicotinamide Adenine Dinucleotide) is not a peptide — it’s a coenzyme that is absolutely essential for life. Found in every cell in the body, NAD+ is involved in hundreds of biological processes including energy production, DNA repair, gene expression, and cellular communication.

What has made NAD+ one of the biggest stories in longevity research is the discovery that its levels decline dramatically with age — by up to 50% between the ages of 40 and 60. This decline has been linked to many of the hallmarks of aging, which has fuelled intense scientific interest in whether restoring NAD+ levels can reverse age-related decline.

What Researchers Are Exploring

Anti-Aging & Longevity NAD+ is considered one of the most important molecules in aging research. It is required for the activity of sirtuins — a family of enzymes often called “longevity genes” — which play key roles in DNA repair, inflammation control, and cellular stress response. Research suggests declining NAD+ may be a root cause of many age-related changes.

Cellular Energy Production NAD+ is essential for converting food into cellular energy through the mitochondria. Research has explored how declining NAD+ levels contribute to reduced energy, fatigue, and metabolic slowdown associated with aging.

DNA Repair NAD+ is consumed by PARP enzymes during the DNA repair process. As NAD+ declines, the body’s ability to repair DNA damage also declines — a process linked to aging and cellular dysfunction. Research has explored whether boosting NAD+ can support the body’s DNA repair capacity.

Brain Health & Neuroprotection The brain is one of the most energy-demanding organs, making it particularly sensitive to NAD+ decline. Research has explored NAD+ supplementation for neuroprotection, cognitive function, and neurodegenerative conditions.

Metabolic Health Studies have examined NAD+’s role in metabolic function, insulin sensitivity, and fat metabolism — with research suggesting that restoring NAD+ may improve metabolic health markers that deteriorate with age.

Worth Noting NAD+ is arguably the single most researched molecule in the longevity and anti-aging field. The depth of published research linking NAD+ decline to aging is extensive, and it sits at the intersection of energy production, DNA repair, and sirtuin activation — three of the most active areas in longevity science.

For research use only. Not intended for human consumption. Not approved by the FDA or TGA.

Pinealon is a synthetic tripeptide — just three amino acids (Glu-Asp-Arg) — developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It belongs to a class of compounds called “bioregulators” — short peptides designed to target specific tissues and restore normal function.

Pinealon specifically targets the central nervous system and pineal gland, making it a compound of interest for researchers studying brain health, neuroprotection, sleep, and cognitive aging.

What Researchers Are Exploring

Neuroprotection & Brain Health Research has explored Pinealon’s ability to protect brain cells from damage caused by oxidative stress, hypoxia (low oxygen), and other harmful conditions. Studies suggest it may support neuronal survival and reduce markers of brain cell damage.

Cognitive Function Studies have examined whether Pinealon can support cognitive function — including learning, memory, and mental clarity — particularly in the context of age-related cognitive decline.

Sleep & Circadian Rhythm Through its influence on the pineal gland, research has explored Pinealon’s effects on melatonin production and sleep quality — suggesting it may help restore more balanced circadian rhythm patterns.

Aging & Neurodegeneration Pinealon has been studied in the context of age-related neurological decline, with research exploring whether bioregulator peptides can slow or reverse deterioration in brain tissue.

Worth Noting Pinealon is part of Professor Khavinson’s broader programme of bioregulator peptide research — the same programme that produced Epitalon. While less well-known than some other peptides, it has a focused research profile relevant to anyone interested in brain health and neuroprotection.

For research use only. Not intended for human consumption. Not approved by the FDA or TGA.

Reta is a next-generation research compound that has attracted significant interest in the metabolic research community. Unlike earlier compounds that target a single pathway, R3TA simultaneously activates three receptors — GLP-1, GIP, and glucagon — making it what researchers call a “triple agonist.”

This triple mechanism gives it a uniquely broad approach to metabolic research. GLP-1 receptor activation is linked to appetite regulation and blood sugar control (the same pathway as Semaglutide). GIP receptor activation adds a complementary metabolic effect. And glucagon receptor activation brings effects on fat burning and energy expenditure that the other two pathways don’t cover. The combination of all three has produced some of the most impressive early results seen in metabolic research.

What Researchers Are Exploring

Weight Loss & Fat Metabolism R3TA’s triple receptor action has produced remarkable results in early research, with data suggesting significant body weight reductions that may outperform existing single and dual agonist compounds. The glucagon receptor activity is believed to drive fat-burning and energy expenditure in ways that GLP-1-only compounds don’t achieve.

Blood Sugar & Insulin Research Through GLP-1 and GIP receptor activity, R3TA has demonstrated strong effects on blood sugar regulation and insulin sensitivity — areas of major importance to diabetes and metabolic research.

Appetite & Energy Regulation Research suggests R3TA reduces food intake while simultaneously increasing energy expenditure — a dual effect that may explain the significant weight-related findings in early studies.

Lipid & Cardiovascular Research The glucagon receptor component gives R3TA a unique ability to influence fat metabolism, with research exploring reductions in triglycerides and improved lipid profiles.

Worth Noting R3TA represents the cutting edge of metabolic peptide research. Its triple agonist profile is genuinely novel — no other widely available research compound hits all three receptors simultaneously. Phase 2 clinical trial data published in the New England Journal of Medicine has been widely noted as some of the most significant findings in the metabolic research space in years.

For research use only. Not intended for human consumption. Not approved by the FDA or TGA.

Semax is a synthetic peptide originally developed to support cognitive function and neurological health. It has been researched for its potential effects on memory, focus, learning, and recovery following neurological injury.

Early studies suggest it may influence brain-derived neurotrophic factor (BDNF) and other pathways involved in brain function.

Tesofensine works in a completely different way from peptide-based weight loss compounds like Semaglutide or TIRZ. Instead of working through gut hormone pathways, it acts directly on the brain’s neurotransmitter systems — specifically by blocking the reuptake of three key brain chemicals: serotonin, dopamine, and noradrenaline. This increases the availability of all three neurotransmitters simultaneously.

Originally developed for Parkinson’s and Alzheimer’s disease research, Tesofensine’s significant effects on body weight were discovered during clinical trials — redirecting research interest toward its metabolic potential.

What Researchers Are Exploring

Appetite & Weight Research Tesofensine has produced some of the most striking weight-related findings seen in Phase II clinical trials — results described in the research literature as among the most significant in obesity pharmacotherapy research. Its triple neurotransmitter mechanism appears to reduce appetite through serotonin and dopamine pathways while increasing energy expenditure through noradrenaline.

Metabolic Rate & Energy Expenditure Research suggests Tesofensine may increase resting metabolic rate and promote thermogenesis — meaning the body burns more energy even at rest. This dual mechanism of reduced intake plus increased output may explain the significant weight findings.

Dopamine & Reward Pathways By modulating dopamine signalling, Tesofensine has drawn interest from researchers studying reward-driven eating and food cravings — a fundamentally different approach from gut hormone compounds.

Neurodegenerative Research Its original research area — Parkinson’s and Alzheimer’s disease — remains scientifically relevant, with studies examining its effects on cognitive function and dopaminergic signalling.

Worth Noting Tesofensine’s triple monoamine mechanism makes it genuinely unique. While most metabolic compounds work through gut hormone (incretin) pathways, Tesofensine works through the brain’s neurotransmitter systems — offering a fundamentally different pharmacological approach. For researchers, this opens up study designs that aren’t possible with GLP-1 based compounds.

For research use only. Not intended for human consumption. Not approved by the FDA or TGA.

TB-500 is a synthetic form of Thymosin Beta-4 — a peptide the body naturally produces and that is found in virtually all human cells. Thymosin Beta-4 plays a key role in how the body repairs damaged tissue, which is why the synthetic version has attracted so much research interest.

What Researchers Are Exploring

Tissue Repair & Wound Healing TB-500’s most studied effect is its ability to promote healing of damaged tissue. Research has shown it can stimulate cell migration — helping repair cells move to where they’re needed — and accelerate wound closure across skin, muscle, tendon, and connective tissue.

Muscle Recovery & Injury Research Studies suggest TB-500 may significantly reduce recovery time from muscle strains and tears, and support repair of tendons and ligaments — areas that are notoriously slow to heal.

Inflammation Reduction Research highlights TB-500’s ability to reduce inflammation at injury sites without broad immune suppression — calming inflammation without shutting down the healing process.

Heart & Blood Vessel Research Studies have explored its potential to support heart tissue repair and promote new blood vessel growth (angiogenesis) — a finding with significant implications for cardiovascular research.

Worth Noting TB-500 is based on a peptide the body already produces naturally. Its broad applicability across multiple tissue types makes it one of the most versatile recovery peptides available. It is frequently studied alongside BPC-157, as the two appear to work through complementary mechanisms.

For research use only. Not intended for human consumption. Not approved by the FDA or TGA.